版本:
中国

BRIEF-Cymabay Therapeutics to initiate its next phase 2 study of MBX-8025

Oct 5 Cymabay Therapeutics :

* Initiates its next phase 2 study of MBX-8025 in primary biliary cholangitis

* Initiation of phase 2 study is expected by year end 2016. Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐